Lucas Hoffman

Lucas Hoffman

University of Washington

H-index: 48

North America-United States

About Lucas Hoffman

Lucas Hoffman, With an exceptional h-index of 48 and a recent h-index of 40 (since 2020), a distinguished researcher at University of Washington, specializes in the field of Microbiology, pediatrics, pulmonology, infectious disease, microbiota.

His recent articles reflect a diverse array of research interests and contributions to the field:

The end of the reign of a “master regulator’’? A defect in function of the LasR quorum sensing regulator is a common feature of Pseudomonas aeruginosa isolates

Understanding the clinical implications of the “non-classical” microbiome in chronic lung disease: a viewpoint

Optimization of Human DNA Depletion and Microbial-enrichment Techniques in DNA Extraction From Oropharyngeal Swabs: Preparing for Shotgun Metagenomic Analysis in the PROMISE …

Upper Respiratory Microbiota and Lower Respiratory Disease in Hospitalized Children in Kenya: A Secondary Pilot Analysis of the Toto Bora Trial

Reverse‐engineered exclusive enteral nutrition in pediatric Crohn's disease: A pilot trial

Alterations in the fecal microbiota in patients with advanced cystic fibrosis liver disease after 6 months of elexacaftor/tezacaftor/ivacaftor

WS05. 06 Phase 1/2a randomized, double-blind, placebo-controlled study: safety, Pk, and Efficacy outcome measures of inhaled Gallium Citrate (AR-501) in P Aeruginosa infected …

Polymicrobial infections and antibiotic treatment patterns for cystic fibrosis pulmonary exacerbations

Lucas Hoffman Information

University

Position

Professor of Pediatrics and Microbiology

Citations(all)

11864

Citations(since 2020)

5686

Cited By

8399

hIndex(all)

48

hIndex(since 2020)

40

i10Index(all)

92

i10Index(since 2020)

82

Email

University Profile Page

University of Washington

Google Scholar

View Google Scholar Profile

Lucas Hoffman Skills & Research Interests

Microbiology

pediatrics

pulmonology

infectious disease

microbiota

Top articles of Lucas Hoffman

Title

Journal

Author(s)

Publication Date

The end of the reign of a “master regulator’’? A defect in function of the LasR quorum sensing regulator is a common feature of Pseudomonas aeruginosa isolates

Mbio

Mylène C Trottier

Thays de Oliveira Pereira

Marie-Christine Groleau

Lucas R Hoffman

Ajai A Dandekar

...

2024/2/5

Understanding the clinical implications of the “non-classical” microbiome in chronic lung disease: a viewpoint

Steven L Taylor

Aurélie Crabbé

Luke R Hoffman

James D Chalmers

Geraint B Rogers

2024/2/1

Optimization of Human DNA Depletion and Microbial-enrichment Techniques in DNA Extraction From Oropharyngeal Swabs: Preparing for Shotgun Metagenomic Analysis in the PROMISE …

DC Bouzek

CE Pope

DJ Wolter

CJ Miller

HS Hayden

...

2024/5

Upper Respiratory Microbiota and Lower Respiratory Disease in Hospitalized Children in Kenya: A Secondary Pilot Analysis of the Toto Bora Trial

LE Ellington

B Singa

K Tickell

P Pavlinac

D Rwigi

...

2024/5

Reverse‐engineered exclusive enteral nutrition in pediatric Crohn's disease: A pilot trial

Journal of Pediatric Gastroenterology and Nutrition

Dale Lee

Kim Braly

Mason Nuding

Ian Braly

Courtney Hopp

...

2024/4/1

Alterations in the fecal microbiota in patients with advanced cystic fibrosis liver disease after 6 months of elexacaftor/tezacaftor/ivacaftor

Journal of Cystic Fibrosis

Jennifer T Duong

Christopher E Pope

Hillary S Hayden

Carson Miller

Stephen J Salipante

...

2024/3/6

WS05. 06 Phase 1/2a randomized, double-blind, placebo-controlled study: safety, Pk, and Efficacy outcome measures of inhaled Gallium Citrate (AR-501) in P Aeruginosa infected …

Journal of Cystic Fibrosis

A Cohen

N Lechtzin

S Boas

T Pena

K McBennett

...

2023/6/1

Polymicrobial infections and antibiotic treatment patterns for cystic fibrosis pulmonary exacerbations

Journal of Cystic Fibrosis

Anna V Faino

Lucas R Hoffman

Ronald L Gibson

Matthew P Kronman

David P Nichols

...

2023/7/1

Pseudomonas aeruginosa Evasion of Neutrophil Antibacterial Functions in Early Cystic Fibrosis Lung Infection

Kelly Kwong

2023

WS13. 05 The short-and long-term effects of antibiotic treatment on the oropharyngeal and fecal microbiota in infants with cystic fibrosis

Journal of Cystic Fibrosis

L Hoffman

H Hayden

M Nelson

S Ross

A Vo

...

2023/6/1

Characterization of cerebrospinal fluid (CSF) microbiota at the time of initial surgical intervention for children with hydrocephalus

Plos one

Shailly Pandey

Kathryn B Whitlock

Matthew R Test

Paul Hodor

Christopher E Pope

...

2023/6/21

Pharmacologic improvement of CFTR function rapidly decreases sputum pathogen density, but lung infections generally persist

The Journal of Clinical Investigation

David P Nichols

Sarah J Morgan

Michelle Skalland

Anh T Vo

Jill M Van Dalfsen

...

2023/5/15

A Refined, Controlled 16S rRNA Gene Sequencing Approach Reveals Limited Detection of Cerebrospinal Fluid Microbiota in Children with Bacterial Meningitis

Microbiology Spectrum

Christopher E Pope

Kathryn B Whitlock

Paul Hodor

David D Limbrick Jr

Patrick J McDonald

...

2023/6/15

147 A multitargeted approach to identify sputum and blood inflammatory cell responses to AR-501 as a measure of treatment response in people with cystic fibrosis

Journal of Cystic Fibrosis

M Saavedra

N Rysavy

K Poch

D Wolter

L Hoffman

...

2023/10/1

Mo1885 FECAL MICROBIOTA CHANGES IN CHILDREN WITH CYSTIC FIBROSIS WITH 1 MONTH OF CFTR MODULATOR THERAPY ELEXACAFTOR/TEZACAFTOR/IVACAFTOR: PRELIMINARY FINDINGS FROM THE PROMISE …

Gastroenterology

Jennifer T Duong

Christopher E Pope

Hillary S Hayden

Carson Miller

Daniel Raftery

...

2023/5/1

P228 In vitro evolution of levofloxacin resistance in lineages of clinical Pseudomonas aeruginosa isolates cultured at different stages of infection from people with cystic …

Journal of Cystic Fibrosis

CM Sloan

LJ Sherrard

GG Einarsson

LR Hoffman

MM Tunney

...

2023/6/1

46 Identifying putative volatile biomarkers for methicillin-resistant Staphylococcus aureus and small-colony variant subtypes

Journal of Cystic Fibrosis

D Gutierrez-Munoz

H Bean

L Hoffman

B Wagner

D Wolter

2023/10/1

Mo1716 REVERSE-ENGINEERED EXCLUSIVE ENTERAL NUTRITION IN ACTIVE PEDIATRIC CROHN'S DISEASE: IMPACT ON DISEASE AND THE INTESTINAL MICROBIOME

Gastroenterology

Dale Lee

Kimberly Braly

Mason E Nuding

Ian Braly

Courtney Hopp

...

2023/5/1

EPS5. 02 Faecal microbiota changes in patients with cystic fibrosis with 6 months of elexacaftor/tezacaftor/ivacaftor: preliminary findings from the PROMISE study

Journal of Cystic Fibrosis

JT Duong

CE Pope

HS Hayden

C Miller

D Raftery

...

2023/6/1

Antibiotic regimen changes during cystic fibrosis pediatric pulmonary exacerbation treatment

Annals of the American Thoracic Society

Jonathan D Cogen

Don B Sanders

James E Slaven

Anna V Faino

Ranjani Somayaji

...

2023/9

See List of Professors in Lucas Hoffman University(University of Washington)